Efficacy of Median Nerve Block Performed Using Echographic Guidance

September 22, 2016 updated by: Hopital Foch
Observational study of the efficacy of median nerve blocks performed using echographic guidance in patients presenting with or without carpal tunnel syndrome.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Suresnes, France, 92150
        • Hopital Foch
      • Trappes, France, 78190
        • Hôpital Privé de l'Ouest Parisien

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients scheduled for hand surgery

Description

Inclusion Criteria:

  • short surgical procedure (less than 30 minutes) on the hand,
  • regional anesthesia at the elbow involving the median nerve.

Exclusion Criteria:

  • age less than 18 years,
  • pregnant woman
  • mental incapacity,
  • poor understanding of French.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
patients with a carpal tunnel syndrome
Procedure: median nerve block
median nerve block performed under echographic guidance
2
patients without a carpal tunnel syndrome
Procedure: median nerve block
median nerve block performed under echographic guidance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
light touch sensibility
Time Frame: 30 minutes following block performance
30 minutes following block performance

Secondary Outcome Measures

Outcome Measure
Time Frame
ice touch sensibility
Time Frame: 30 minutes following block performance
30 minutes following block performance
motor block
Time Frame: 30 minutes following block performance
30 minutes following block performance
paresthesia
Time Frame: during nerve block procedure
during nerve block procedure
vascular puncture
Time Frame: during nerve block procedure
during nerve block procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hopital Foch

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2009

Primary Completion (Actual)

May 1, 2009

Study Completion (Actual)

May 1, 2009

Study Registration Dates

First Submitted

February 2, 2009

First Submitted That Met QC Criteria

February 2, 2009

First Posted (Estimate)

February 3, 2009

Study Record Updates

Last Update Posted (Estimate)

September 23, 2016

Last Update Submitted That Met QC Criteria

September 22, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 2008/42

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthopedic

Clinical Trials on median nerve block

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe